These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22684996)

  • 1. Regulatory T cells participate in CD39-mediated protection from renal injury.
    Wang YM; McRae JL; Robson SC; Cowan PJ; Zhang GY; Hu M; Polhill T; Wang Y; Zheng G; Wang Y; Lee VW; Unwin RJ; Harris DC; Dwyer KM; Alexander SI
    Eur J Immunol; 2012 Sep; 42(9):2441-51. PubMed ID: 22684996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD39+ regulatory T cells attenuate allergic airway inflammation.
    Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
    Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice.
    Lee H; Nho D; Chung HS; Lee H; Shin MK; Kim SH; Bae H
    Kidney Int; 2010 Dec; 78(11):1100-9. PubMed ID: 20463654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells regulate the distribution of natural killer T cells through CD39 signal transduction in asthma.
    Lu Y; Li Y; Zhou W; Ding B; Yu Q
    Hum Cell; 2019 Apr; 32(2):141-149. PubMed ID: 30539423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.
    Borsellino G; Kleinewietfeld M; Di Mitri D; Sternjak A; Diamantini A; Giometto R; Höpner S; Centonze D; Bernardi G; Dell'Acqua ML; Rossini PM; Battistini L; Rötzschke O; Falk K
    Blood; 2007 Aug; 110(4):1225-32. PubMed ID: 17449799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The abnormal function of CD39
    Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
    Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.
    Kochetkova I; Golden S; Holderness K; Callis G; Pascual DW
    J Immunol; 2010 Jun; 184(12):7144-53. PubMed ID: 20483737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.
    Bertelli R; Bodria M; Nobile M; Alloisio S; Barbieri R; Montobbio G; Patrone P; Ghiggeri GM
    Clin Exp Immunol; 2011 Oct; 166(1):55-63. PubMed ID: 21762125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.
    Jenabian MA; Seddiki N; Yatim A; Carriere M; Hulin A; Younas M; Ghadimi E; Kök A; Routy JP; Tremblay A; Sévigny J; Lelievre JD; Levy Y
    PLoS Pathog; 2013; 9(4):e1003319. PubMed ID: 23658513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.
    Hilchey SP; Kobie JJ; Cochran MR; Secor-Socha S; Wang JC; Hyrien O; Burack WR; Mosmann TR; Quataert SA; Bernstein SH
    J Immunol; 2009 Nov; 183(10):6157-66. PubMed ID: 19864600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
    Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
    Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
    Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
    Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
    Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
    Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
    Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role?
    Salcido-Ochoa F; Tsang J; Tam P; Falk K; Rotzschke O
    Transplant Rev (Orlando); 2010 Apr; 24(2):52-66. PubMed ID: 20153159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism.
    Xia N; Jiao J; Tang TT; Lv BJ; Lu YZ; Wang KJ; Zhu ZF; Mao XB; Nie SF; Wang Q; Tu X; Xiao H; Liao YH; Shi GP; Cheng X
    Clin Sci (Lond); 2015 May; 128(10):679-93. PubMed ID: 25558978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.
    Boer MC; van Meijgaarden KE; Bastid J; Ottenhoff TH; Joosten SA
    Eur J Immunol; 2013 Jul; 43(7):1925-32. PubMed ID: 23606272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations.
    Zhou Q; Yan J; Putheti P; Wu Y; Sun X; Toxavidis V; Tigges J; Kassam N; Enjyoji K; Robson SC; Strom TB; Gao W
    Am J Transplant; 2009 Oct; 9(10):2303-11. PubMed ID: 19656134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism.
    Ring S; Oliver SJ; Cronstein BN; Enk AH; Mahnke K
    J Allergy Clin Immunol; 2009 Jun; 123(6):1287-96.e2. PubMed ID: 19427686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.